In Vitro Performance of Dutasteride-Nanostructured Lipid Carriers Coated with Lauric Acid-Chitosan Oligomer for Dermal Delivery

Dutasteride, licensed as an oral medicine for the treatment of benign prostatic hypoplasia, has been investigated as a treatment for androgenic alopecia. In this study, the potential for dustasteride to be delivered topically in order to reduce systemic exposure, irritation of the skin, and also cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Noor, Norhayati Mohamed, Abdul-Aziz, Azila, Sheikh, Khalid, Somavarapu, Satyanarayana, Taylor, Kevin M. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589135/
https://www.ncbi.nlm.nih.gov/pubmed/33092119
http://dx.doi.org/10.3390/pharmaceutics12100994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589135/
https://www.ncbi.nlm.nih.gov/pubmed/33092119
http://dx.doi.org/10.3390/pharmaceutics12100994

Ejemplares similares